| Patient | Johnny Cash |
|---|---|
| Date of birth | 1932-02-26 |
| Identifiers | MRN HR-ML004-SYN-TD; SSN (made up) 000-04-8125 |
| Document date | 2026-11-01 |
| Author | Gideon Hale, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care new-patient visit for diabetes, lightheadedness on standing, and glaucoma follow-up. Concerns: Lightheaded when he stands and afraid of another fall; was once told he had Shy-Drager syndrome and wants to know what he really has; Wants to keep the sight he has left so he can keep writing songs. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 500 mg oral tablet, one tablet by mouth twice daily with meals | One tablet by mouth twice daily with meals | Oral route | 2001-05-06 to 2003-02-27 | completed | S |
| Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals | One tablet by mouth twice daily with meals | Oral route | 2003-02-27 | active | S |
| Sitagliptin 100 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2003-03-27 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2003-02-27 | active | S |
| Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtime | One drop in each eye at bedtime | Ophthalmic route | 2000-09-11 | active | S |
| Dorzolamide 2% ophthalmic solution, one drop in each eye twice daily | One drop in each eye twice daily | Ophthalmic route | 2003-02-27 | active | S |
| Midodrine 2.5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PM | One tablet by mouth on waking, at midday, and mid-afternoon; last dose at least four hours before bed | Oral route | 2003-03-27 to 2003-05-29 | completed | S |
| Midodrine 5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PM | One tablet by mouth on waking, at midday, and mid-afternoon; last dose at least four hours before bed | Oral route | 2003-05-29 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Comprehensive diabetic foot examination with 10-g monofilament and vibration testing | 2003-02-27 to 2003-02-27 | completed | S |
| Optical coherence tomography of the optic nerve and retinal nerve fiber layer, both eyes | 2003-02-27 to 2003-02-27 | completed | S |
| Dilated eye examination and Humphrey 24-2 visual field testing, both eyes | 2003-02-27 to 2003-02-27 | completed | S |
| Optical coherence tomography of the optic nerve and retinal nerve fiber layer, both eyes | 2003-08-14 to 2003-08-14 | completed | S |
| Humphrey 24-2 visual field testing, both eyes | 2003-08-14 to 2003-08-14 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2002-10-20 | High-dose influenza vaccine, 2002-2003 season | completed | S |
| 2003-02-27 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 2003-05-29 | Recombinant zoster vaccine, dose 1 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1957 | Amphetamine use beginning in 1957, with barbiturates in the 1960s; addiction lasting about a decade | D (CLM-0004) |
| 1983 | Hospitalized in 1983 with internal bleeding, followed by treatment at the Betty Ford Clinic | D (CLM-0005) |
| October 1997 | Diagnosed with Shy-Drager syndrome in October 1997; he said in 2000 that it was a misdiagnosis, and autonomic neuropathy was later identified | D (CLM-0006, CLM-0007) |
| February 2001 | Pneumonia treated at Baptist Hospital in Nashville in February 2001, one of several pneumonia admissions | D (CLM-0008) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| brother | Older brother Jack died in a sawmill accident in 1944 | D (CLM-0003) |
| Concern | Status | Evidence |
|---|---|---|
| Lightheaded when he stands and afraid of another fall; was once told he had Shy-Drager syndrome and wants to know what he really has | active | S |
| Wants to keep the sight he has left so he can keep writing songs | active | S |
Most recent measures: Hemoglobin A1c/Hemoglobin.total in Blood 7.3 on 2003-08-14; Sodium [Moles/volume] in Serum or Plasma 140 on 2003-08-14; Potassium [Moles/volume] in Serum or Plasma 4.5 on 2003-08-14; Creatinine [Mass/volume] in Serum or Plasma 1.05 on 2003-08-14; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M 73 on 2003-08-14; Glucose [Mass/volume] in Serum or Plasma 131 on 2003-08-14; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 74 on 2003-05-29; Albumin/Creatinine [Mass Ratio] in Urine 16 on 2003-08-14; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 on 2003-05-29; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 2003-02-27; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 286 on 2003-02-27; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 2003-02-27; Hemoglobin [Mass/volume] in Blood 13.8 on 2003-02-27; Right eye Intraocular pressure 14 on 2003-08-14; Left eye Intraocular pressure 15 on 2003-08-14; Right retina Retinal nerve fiber layer.mean thickness by OCT 60 on 2003-08-14; Left retina Retinal nerve fiber layer.mean thickness by OCT 57 on 2003-08-14; Visual acuity best corrected Right eye by ETDRS eye chart 68 on 2003-08-14; Visual acuity best corrected Left eye by ETDRS eye chart 62 on 2003-08-14; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2003-04-24; Total score [Mini-Cog] 5 on 2003-02-27; Total score [AUDIT-C] 0 on 2003-04-24 [S]
Strengths and supports: Supports: a family member who comes to visits and fills his pill organizer, and his church community [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Type 2 diabetes mellitus with diabetic autonomic neuropathy; HbA1c above the individualized goal at intake | active | confirmed | E11.43 | S — Synthetic modern diagnosis linked to the publicly reported diabetes and autonomic neuropathy. |
| Neurogenic orthostatic hypotension from diabetic autonomic neuropathy | active | confirmed | I95.1 | S — Synthetic finding; explains the autonomic symptoms once labeled Shy-Drager syndrome. |
| Diabetic distal symmetric polyneuropathy with loss of protective sensation in both feet | active | confirmed | E11.42 | S — Synthetic finding linked to his description of numb lower extremities. |
| Primary open-angle glaucoma, both eyes, severe stage | active | confirmed | H40.1133 | S — Synthetic modern diagnosis; the type and stage are not documented historically. |
| Mild nonproliferative diabetic retinopathy without macular edema, both eyes | active | confirmed | E11.3293 | S — Synthetic finding from the dilated eye examination. |
| Hyperlipidemia | active | confirmed | E78.5 | S — Synthetic finding from the baseline LDL cholesterol. |
| History of recurrent pneumonia | active | confirmed | Z87.01 | S — Synthetic modern coding of the documented recurrent pneumonia; supports pneumococcal vaccination. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2003-02-27 | Hemoglobin A1c/Hemoglobin.total in Blood | 8.6 | % | <=5.6% | High | S |
| 2003-02-27 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2003-02-27 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2003-02-27 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2003-02-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M | 74 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2003-02-27 | Glucose [Mass/volume] in Serum or Plasma | 186 | mg/dL | 70-99 mg/dL | High | S |
| 2003-02-27 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 128 | mg/dL | <=99 mg/dL | High | S |
| 2003-02-27 | Albumin/Creatinine [Mass Ratio] in Urine | 18 | mg/g | <=30 mg/g | Normal | S |
| 2003-02-27 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-56 U/L | Normal | S |
| 2003-02-27 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 10-40 U/L | Normal | S |
| 2003-02-27 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 286 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2003-02-27 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2003-02-27 | Hemoglobin [Mass/volume] in Blood | 13.8 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2003-02-27 | Right eye Intraocular pressure | 22 | mm[Hg] | 10-21 mmHg | High | S |
| 2003-02-27 | Left eye Intraocular pressure | 24 | mm[Hg] | 10-21 mmHg | High | S |
| 2003-02-27 | Right retina Retinal nerve fiber layer.mean thickness by OCT | 61 | um | 80-120 um | Low | S |
| 2003-02-27 | Left retina Retinal nerve fiber layer.mean thickness by OCT | 57 | um | 80-120 um | Low | S |
| 2003-02-27 | Visual acuity best corrected Right eye by ETDRS eye chart | 68 | {letters} | >=80 | Low | S |
| 2003-02-27 | Visual acuity best corrected Left eye by ETDRS eye chart | 63 | {letters} | >=80 | Low | S |
| 2003-02-27 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2003-02-27 | Total score [Mini-Cog] | 5 | {score} | S | ||
| 2003-03-27 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2003-03-27 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2003-03-27 | Creatinine [Mass/volume] in Serum or Plasma | 1.06 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2003-03-27 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M | 72 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2003-03-27 | Glucose [Mass/volume] in Serum or Plasma | 152 | mg/dL | 70-99 mg/dL | High | S |
| 2003-05-29 | Hemoglobin A1c/Hemoglobin.total in Blood | 7.7 | % | <=5.6% | High | S |
| 2003-05-29 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 74 | mg/dL | <=99 mg/dL | Normal | S |
| 2003-05-29 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 27 | U/L | 7-56 U/L | Normal | S |
| 2003-05-29 | Right eye Intraocular pressure | 15 | mm[Hg] | 10-21 mmHg | Normal | S |
| 2003-05-29 | Left eye Intraocular pressure | 16 | mm[Hg] | 10-21 mmHg | Normal | S |
| 2003-05-29 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2003-08-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 7.3 | % | <=5.6% | High | S |
| 2003-08-14 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2003-08-14 | Potassium [Moles/volume] in Serum or Plasma | 4.5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2003-08-14 | Creatinine [Mass/volume] in Serum or Plasma | 1.05 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2003-08-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M | 73 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2003-08-14 | Glucose [Mass/volume] in Serum or Plasma | 131 | mg/dL | 70-99 mg/dL | High | S |
| 2003-08-14 | Albumin/Creatinine [Mass Ratio] in Urine | 16 | mg/g | <=30 mg/g | Normal | S |
| 2003-08-14 | Right eye Intraocular pressure | 14 | mm[Hg] | 10-21 mmHg | Normal | S |
| 2003-08-14 | Left eye Intraocular pressure | 15 | mm[Hg] | 10-21 mmHg | Normal | S |
| 2003-08-14 | Right retina Retinal nerve fiber layer.mean thickness by OCT | 60 | um | 80-120 um | Low | S |
| 2003-08-14 | Left retina Retinal nerve fiber layer.mean thickness by OCT | 57 | um | 80-120 um | Low | S |
| 2003-08-14 | Visual acuity best corrected Right eye by ETDRS eye chart | 68 | {letters} | >=80 | Low | S |
| 2003-08-14 | Visual acuity best corrected Left eye by ETDRS eye chart | 62 | {letters} | >=80 | Low | S |
| 2003-04-24 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2003-04-24 | Total score [AUDIT-C] | 0 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2003-02-27 | Body height | 188 | cm | S |
| 2003-02-27 | Body weight | 96 | kg | S |
| 2003-02-27 | Body mass index (BMI) [Ratio] | 27.2 | kg/m2 | S |
| 2003-02-27 | Systolic blood pressure | 146 | mm[Hg] | S |
| 2003-02-27 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2003-02-27 | Heart rate | 78 | /min | S |
| 2003-02-27 | Respiratory rate | 16 | /min | S |
| 2003-02-27 | Body temperature | 36.7 | Cel | S |
| 2003-02-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| 2003-03-27 | Body height | 188 | cm | S |
| 2003-03-27 | Body weight | 95 | kg | S |
| 2003-03-27 | Body mass index (BMI) [Ratio] | 26.9 | kg/m2 | S |
| 2003-03-27 | Systolic blood pressure | 142 | mm[Hg] | S |
| 2003-03-27 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2003-03-27 | Heart rate | 76 | /min | S |
| 2003-03-27 | Respiratory rate | 16 | /min | S |
| 2003-03-27 | Body temperature | 36.6 | Cel | S |
| 2003-03-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| 2003-05-29 | Body height | 188 | cm | S |
| 2003-05-29 | Body weight | 93.5 | kg | S |
| 2003-05-29 | Body mass index (BMI) [Ratio] | 26.5 | kg/m2 | S |
| 2003-05-29 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2003-05-29 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2003-05-29 | Heart rate | 74 | /min | S |
| 2003-05-29 | Respiratory rate | 16 | /min | S |
| 2003-05-29 | Body temperature | 36.7 | Cel | S |
| 2003-05-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 2003-08-14 | Body height | 188 | cm | S |
| 2003-08-14 | Body weight | 92.5 | kg | S |
| 2003-08-14 | Body mass index (BMI) [Ratio] | 26.2 | kg/m2 | S |
| 2003-08-14 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2003-08-14 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2003-08-14 | Heart rate | 72 | /min | S |
| 2003-08-14 | Respiratory rate | 16 | /min | S |
| 2003-08-14 | Body temperature | 36.6 | Cel | S |
| 2003-08-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 2003-04-24 | Body height | 188 | cm | S |
| 2003-04-24 | Body weight | 94.2 | kg | S |
| 2003-04-24 | Body mass index (BMI) [Ratio] | 26.7 | kg/m2 | S |
| 2003-04-24 | Systolic blood pressure | 138 | mm[Hg] | S |
| 2003-04-24 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2003-04-24 | Heart rate | 75 | /min | S |
| 2003-04-24 | Respiratory rate | 16 | /min | S |
| 2003-04-24 | Body temperature | 36.6 | Cel | S |
| 2003-04-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2003-02-27 | Primary care new-patient visit for diabetes, lightheadedness on standing, and glaucoma follow-up | finished | S |
| 2003-03-27 | Endocrinology consultation for diabetes and autonomic neuropathy | finished | S |
| 2003-05-29 | Three-month diabetes, blood pressure, and eye pressure review | finished | S |
| 2003-08-14 | Six-month diabetes review with glaucoma imaging | finished | S |
| 2003-04-24 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Increase metformin to 1000 mg twice daily and set an individualized HbA1c goal below 7.5%; avoid insulin and sulfonylureas while autonomic neuropathy may blunt warning symptoms of hypoglycemia | completed | GL-ADA-2025, GL-CMID-2026 | S |
| Endocrinology consultation to confirm diabetic autonomic neuropathy as the cause of orthostatic hypotension, reconsider the earlier Shy-Drager label, and choose add-on glucose-lowering therapy | completed | GL-ADA-2025 | S |
| Treat neurogenic orthostatic hypotension: stand up in stages, raise the head of the bed, use waist-high compression, drink 2 liters of fluid a day, then midodrine with the last dose at least four hours before bed; check supine blood pressure at each visit | completed | GL-ADA-2025 | S |
| Check HbA1c every three months until at goal, a basic metabolic panel, UACR, and lipids each year, lipids 4 to 12 weeks after starting a statin, and vitamin B12 periodically on metformin | completed | GL-CMID-2026, GL-ADA-2025 | S |
| Examine the feet at every visit because of sensory loss; daily self-inspection and protective footwear | completed | GL-ADA-2025, GL-CMID-2026 | S |
| Coordinate glaucoma care with the eye clinic: add dorzolamide to latanoprost, check pressure at each visit, and repeat OCT and visual fields every six months; avoid timolol and brimonidine because of bradycardia, bronchospasm, and low blood pressure | completed | GL-AAO-POAG-2025, GL-CMID-2026 | S |
| Annual dilated eye examination for diabetic retinopathy; low-vision rehabilitation and home lighting review | completed | GL-ADA-2025, GL-AAO-POAG-2025 | S |
| Start atorvastatin 40 mg; give PCV20 and recombinant zoster vaccines | completed | GL-ADA-2025 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Reach an HbA1c below 7.5% without hypoglycemia by the six-month review | 2003-08-14 | completed | HbA1c fell from 8.6% to 7.3% with no hypoglycemia | S |
| No falls and a standing systolic pressure of 100 mm Hg or more by the six-month review | 2003-08-14 | completed | No falls since the second visit; 134/74 seated and 120/70 standing on midodrine | S |
| Lower intraocular pressure to 16 mm Hg or less in each eye by the three-month review | 2003-05-29 | completed | Pressure 15 mm Hg right and 16 mm Hg left at three months | S |
| LDL cholesterol below 70 mg/dL by the six-month review | 2003-08-14 | active | LDL 74 mg/dL at three months; recheck at the annual visit | S |